Hung Anna, Stuart Bruce, Harris Ilene
University of Maryland, School of Pharmacy, 220 South Arch St, Baltimore, MD 21201. E-mail:
Am J Manag Care. 2016 Feb 1;22(2):e53-9.
To compare the rates of mammographic screening and reasons for not receiving mammography between Medicare Advantage (MA) and Medicare fee-for-service (FFS) beneficiaries.
Cross-sectional study.
Unadjusted rates of mammographic screening and reasons for not receiving mammography were compared between MA and FFS beneficiaries in total and within subgroups. Probabilities of mammographic screening were also compared between the MA and FFS beneficiaries after adjusting for age, education, race/ethnicity, health status, marriage status, and region of residence using modified Poisson regression models.
We found significantly higher unadjusted rates of mammographic screening in the MA beneficiary population compared with the FFS population (50.3% vs 44%, respectively; P < .0001). MA beneficiaries were more likely to receive a mammogram than FFS beneficiaries (unadjusted relative risk [RR], 1.13; 95% CI, 1.07-1.19; and adjusted RR, 1.06; 95% CI, 1.01-1.12). Furthermore, the top 6 reasons why MA and FFS beneficiaries did not receive mammograms were: "not needed," "doctor did not recommend," "forgot," "not recommended annually," "did not like mammograms," and "appointment due soon." Among non-Hispanic blacks and Hispanics specifically, FFS beneficiaries were more likely to report doctors not recommending mammograms than MA beneficiaries.
MA beneficiaries were 1.06 times more likely to receive mammography screening compared with the FFS population. Additionally, providers were less likely to recommend mammographic screening to non-Hispanic black and Hispanic FFS beneficiaries compared with non-Hispanic black and Hispanic MA beneficiaries.
比较医疗保险优势(MA)受益人和传统医疗保险按服务收费(FFS)受益人进行乳腺钼靶筛查的比例以及未接受乳腺钼靶检查的原因。
横断面研究。
比较MA受益人和FFS受益人总体及亚组中未经调整的乳腺钼靶筛查比例和未接受乳腺钼靶检查的原因。还使用修正的泊松回归模型,在调整年龄、教育程度、种族/族裔、健康状况、婚姻状况和居住地区后,比较MA受益人和FFS受益人进行乳腺钼靶筛查的概率。
我们发现,MA受益人群中未经调整的乳腺钼靶筛查比例显著高于FFS人群(分别为50.3%和44%;P <.0001)。MA受益人比FFS受益人更有可能接受乳腺钼靶检查(未经调整的相对风险[RR]为1.13;95%可信区间为1.07 - 1.19;调整后的RR为1.06;95%可信区间为1.01 - 1.12)。此外,MA受益人和FFS受益人未接受乳腺钼靶检查的前6个原因是:“不需要”、“医生未推荐”、“忘记了”、“不建议每年检查”、“不喜欢乳腺钼靶检查”和“预约时间快到了”。特别是在非西班牙裔黑人和西班牙裔中,FFS受益人比MA受益人更有可能报告医生不推荐进行乳腺钼靶检查。
与FFS人群相比,MA受益人接受乳腺钼靶筛查的可能性高1.06倍。此外,与非西班牙裔黑人和西班牙裔MA受益人相比,医疗服务提供者向非西班牙裔黑人和西班牙裔FFS受益人推荐乳腺钼靶筛查的可能性较小。